Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

May 31, 2016

Conditions
Leukemia
Interventions
GENETIC

gene expression analysis

GENETIC

gene rearrangement analysis

GENETIC

polymerase chain reaction

GENETIC

protein analysis

GENETIC

western blotting

OTHER

laboratory biomarker analysis

OTHER

mass spectrometry

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT01500499 - Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter